Gap-SKIN Draft: Redefining Dermatology for 2026

The Gap-SKIN Draft is about to completely overhaul how we practice dermatology, from our core dermatology guidelines to how we interact with patients. This isn’t just another policy paper. It’s a framework designed to standardize our wildly variable practices, force us to adopt new technologies, and build patient input into every single treatment plan. It will fundamentally change the day-to-day management of skin health.

The Imperative for Standardized Dermatology Guidelines

Let’s be honest, the explosion of new research and therapies has made dermatology an incredibly complex field to navigate. With no universally accepted dermatology guidelines, patient care varies dramatically from one clinic to another, leading to inconsistent results and frankly, some suboptimal outcomes. We’ve seen this happen for years in sub-specialties where the lack of consensus on something as basic as acne treatment protocols slows down the adoption of better approaches. The Gap-SKIN Draft aims to fix this by proposing a unified set of protocols that establish a clear baseline of quality for every practice.

For a long time, we’ve relied on individual practitioners or small groups to create their own “best practices.” While we all value professional autonomy, there’s an undeniable collective benefit to having a standardized, evidence-based approach. A patient with a chronic condition like psoriasis or eczema can move from Florida to Oregon and get two completely different treatment plans, which can seriously derail their long-term health. The Gap-SKIN initiative is designed to close those geographic and institutional gaps by creating a floor for quality care (it’s not a ceiling). The American Academy of Dermatology (AAD) has been pushing for this for years, and as they note in their policy statement on clinical practice standards (AAD Guidelines of Care), this draft is a major step toward that goal.

Integrating Advanced Technology for Enhanced Skin Health

2026 is the deadline for a major tech upgrade in healthcare, and the Gap-SKIN Draft is putting artificial intelligence (AI) and machine learning (ML) front and center in our diagnostic and treatment work. This goes way beyond just using AI for basic image analysis. We’re now expected to use predictive analytics that can forecast disease progression or a patient’s response to treatment based on their specific genetic profile and lifestyle data. This type of personalized medicine is quickly becoming a standard part of modern dermatology. For example, AI diagnostic tools from companies like DermTech are already finding melanoma early with impressive accuracy.

Telemedicine is also getting a serious upgrade under these new guidelines. Virtual consultations are now a foundational piece of providing accessible care, especially for people in rural areas or those who can’t easily travel. The Draft specifies requirements for secure, high-def video and integrated electronic health record (EHR) systems so data can move smoothly between a virtual consult and an in-person visit. This means a remote diagnosis of a suspicious lesion can get an in-person biopsy scheduled immediately, without the usual headaches of redundant data entry. The ethical side of using AI in patient care is also getting a lot of attention, with clear rules on data privacy, algorithmic bias, and the fact that the human clinician is always the one who is in the end responsible. We have to make sure these tools help us think better, not replace our clinical judgment.

The Central Role of Patient Input

The biggest change coming with the Gap-SKIN Draft is its absolute insistence on patient input. The old “doctor knows best” approach to medical decisions is on its way out. The new guidelines require us to use shared decision-making models, where we are obligated to present all the treatment options, clearly explain the real-world risks and benefits, and then actively work with the patient to finalize a plan that fits their life. This isn’t about checking a box. It’s about building a partnership so people can actually manage their own skin health.

Take a patient with severe acne. In the past, a derm might just prescribe a strong systemic drug with known side effects. Under this new framework, the conversation has to include the patient’s lifestyle, their specific worries about those side effects, and what they’re actually trying to achieve. Maybe they’d prefer a less aggressive treatment that fits their routine, even if it takes longer. That conversation matters. The UK’s National Institute for Health and Care Excellence (NICE) has been doing this for years, and their guides on shared decision-making are a great model for what the Gap-SKIN approach is trying to achieve (NICE Shared Decision Making). The guidelines also demand patient education materials that are easy to understand, culturally aware, and available in different languages, so that “informed consent” is actually informed.

Redefining Skin Health Standards and Outcomes

The Gap-SKIN Draft looks beyond the individual clinic and sets new public skin health standards. It provides a real structure for public health work, with a focus on preventative care, early detection campaigns, and education about sun protection and basic skin hygiene. The guidelines propose, for instance, standardized screening protocols for common skin cancers, telling us exactly how often to screen patients based on their specific risk factors. This proactive work is aimed at lowering the massive burden of preventable skin diseases.

The Draft is also getting much stricter about how we measure treatment success. It’s not enough to just say the symptoms are gone. The new standards require us to track patient-reported outcomes (PROs), quality of life scores, and long-term remission rates. This gives us a much more complete picture, because skin conditions have huge psychological and social effects. A treatment might clear up a rash, but if the side effects destroy a patient’s quality of life, can we really call it a success? This push for PROs is happening everywhere in healthcare, and it’s right, the patient’s experience is the ultimate measure of whether what we did actually worked. Dermatologists in Georgia, for instance, will soon have to build PROs right into their electronic charts at clinics like Emory Healthcare in Atlanta, which is a major change from just making clinical notes (Emory Dermatology).

Professional Development and Ethical Considerations

For any of this to work, we’re all going to need more training. A lot more. The Gap-SKIN Draft lays out mandatory professional development modules in digital literacy, the ethical application of AI, and the communication skills required for real shared decision-making. These aren’t optional courses. They’re going to be part of maintaining our certification and staying compliant. The American Board of Dermatology is already updating its maintenance of certification program to include continuous learning on these exact topics.

There’s also a much stronger focus on ethics, especially around data privacy and using AI responsibly. The Draft has strict rules for anonymizing patient data, getting explicit consent before sharing it, and auditing AI algorithms for bias. This is critical. A biased algorithm could easily make health disparities worse. For example, if a diagnostic AI is only trained on images of light skin, it will fail when evaluating conditions on darker skin, leading to misdiagnoses. The guidelines are trying to get ahead of these problems to make sure new technology helps everyone. If we don’t get the ethical framework right from the start, the tech could do more harm than good, and that’s a risk we can’t take.

The Gap-SKIN Draft is a forward-thinking plan for dermatology. It’s a plan that’s built on evidence-based practice, technology, and, most importantly, the patient’s own voice. Getting these guidelines adopted will mean our care becomes more consistent, more effective, and finally, truly centered on the person we’re treating.